Second hematopoietic SCT in patients with thalassemia recurrence following rejection of the first graft
- 23 June 2008
- journal article
- clinical trial
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 42 (6) , 397-404
Abstract
There is a substantial incidence of graft failure in patients with thalassemia after myeloablative conditioning regimens especially in class 3 patients in whom its incidence could be as high as 8–38.5%. Most patients with graft failure have recurrence of thalassemic marrow. Historically, results of second transplants for thalassemia were poor because of a high rejection rate and/or increased TRM. Sixteen patients with thalassemia recurrence following rejection of the first graft and with a median age of 9 years (range, 4–20) were given second transplants using BM (n=7) or PBSC (n=9) after preparation with a new treatment protocol. All but two patients received stem cells from the same donor. The median interval between two transplants was 28 months (range, 8–204). The sustained engraftment rate was high (94%) with only one patient having primary graft failure. The probability of overall survival, event-free survival, TRM and graft failure were 79, 79, 16 and 6%, respectively. There were three transplant-related deaths. Thirteen patients are alive with Lansky/Karnofsky score of 100. This intensified treatment protocol was well tolerated with no significant increase in toxicity. The excellent results obtained with this new preparative regimen allow us to recommend it for second transplantation for patients with thalassemia recurrence.Keywords
This publication has 21 references indexed in Scilit:
- Allogeneic stem cell transplantation from matched related and unrelated donors in thalassemia major patients using a reduced toxicity fludarabine-based regimenBone Marrow Transplantation, 2007
- Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemiaBlood, 2007
- New approach for bone marrow transplantation in patients with class 3 thalassemia aged younger than 17 yearsBlood, 2004
- Toward a myeloablative regimen with clinical potential: II. Treosulfan induces specific skin graft tolerance across haploidentical MHC barriersBone Marrow Transplantation, 2003
- Second marrow transplants for graft failure in patients with thalassemiaBone Marrow Transplantation, 1999
- The role of thiotepa in allogeneic bone marrow transplantation for genetic diseasesBone Marrow Transplantation, 1999
- Thiotepa improves allogeneic bone marrow engraftment without enhancing stem cell depletion in irradiated miceBone Marrow Transplantation, 1998
- Immunophenotyping of blood lymphocytes in childhoodReference values for lymphocyte subpopulationsThe Journal of Pediatrics, 1997
- Bone Marrow Transplantation in Patients with ThalassemiaNew England Journal of Medicine, 1990
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958